Immune checkpoint markers such as PD-1, 4-1BB, and Tim-3 also showed sequential expression elevated with closer proximity to tumor cell islets, whereas CD3 showed lowered expression in infiltrated and boundary T-cells (Figure 4D). The gene discussed is HAVCR2; the disease is neoplasm.